Fineotex Chemical Limited · NSE:FCL
Fineotex Chemical — Investor Presentation (February 2021)
31 slides from Fineotex Chemical's investor presentation, Feb 3, 2021
Slide 1: Fineotex Chemical Limited
— ———— / FINEOTEX” _ ASpeciality Chemical Producing Public Listed Company 2 ‘= ‘erage = @e 3" February, 2021 To. General Manager, The Manager, Listing Department, Listing & Compliance Department BSE Limited, The National Stock Exchange of India Limited P.J. Towers, Dalal Street, Exchange Plaza, Band
Slide 2: Fineotex Chemical Limited Investor Presentation February 2021
Fineotex Chemical Limited (BSE: 533333; NSE: FCL) Investor Presentation February 2021 Drilling Specialties Textile Specialties Home Care and Hygiene Specialties Other Specialties
Slide 3: Agenda
Agenda Company Overview 3 – 15 Sustainability Approach 16 – 22 Financial Performance 23 – 28 2
Slide 4: Company Overview
Company Overview 3
Slide 5: An Introduction to Fineotex
An Introduction to Fineotex Speciality chemicals producer for 4+ decades with a market 450+ 60+ leading position in the international textiles industry Product Categories Countries Present Bluesign, ZDHC, 43,000+ MT p.a. Successful entry into home care and hygiene and drilling Star Export House Inst
Slide 6: Fineotex Investment Case
Fineotex Investment Case Business Dynamics Acquisition Track Record Global Customer Reach • Fineotex and Biotex associated with • Biotex (73% owned) net profit has • International acceptance by high quality and innovation across grown by a factor of 4x since profile customers industries globally acq
Slide 7: Our Evolution
Our Evolution 1995 2004 2007 2011 2014 ❖ Incorporation of ❖ Accredited with ❖ Acquisition of FCPL ❖ Listed on BSE ❖ Bonus declared on 1:1 Fineotex ISO 9001:2008 by Fineotex Chemical ❖ Incorporated wholly owned basis Chemical ❖ Incorporation of Limited subsidiary in Malaysia ❖ Accredited with ISO Ind
Slide 8: Driving Future Growth
Driving Future Growth Home Care Specialities Hygiene Specialities Textile Specialities Drilling Specialities Leverage core manufacturing and development expertise into new high growth areas 7
Slide 9: Focus on Growth and Diversification
Focus on Growth and Diversification Home Care and Hygiene Chemicals Drilling Speciality Chemicals Other Speciality Chemicals • Customised solutions for: • Customised solutions for Oil and Gas • A unique ‘Mosquito Life Cycle Controller’ ▪ FMCG - branded detergents • Significant potential for offering
Slide 10: Upcoming Facility at Ambernath, Maharashtra
Upcoming Facility at Ambernath, Maharashtra ➢ Located on ~4 acres of land ➢ The facility is progressing as per schedule and is expected to be commissioned in Q1 FY2022 ➢ Proposed deployment of Rs. 270 million ➢ Cater to customer demands in the existing Textile Specialities and fast growing Home Care
Slide 11: Synergistic Business Model
Synergistic Business Model Fineotex - India Biotex - Malaysia • Diverse product portfolio (400+ categories) • Niche product portfolio (50+ categories) across business segments Overview • High end super speciality textile chemical • Applications primarily across the entire textile applications value
Slide 12: Specialty Textile Chemicals Overview
Specialty Textile Chemicals Overview Steps Weaving Pre-treatment Dyeing Printing Finishing De-sizing, Dyeing, Rotary Exhaust Process Sizing Scouring, Washing, Printing, Padding Bleach Fixing Table Printing Enzymes, Dyes, Acids, Dyes, Binder Softeners, Wetting & Alkali Thickener, Fixer Product Polyme
Slide 13: New Product Offerings from Biotex
New Product Offerings from Biotex ‘The Bioguard Series’ of products from Biotex with water and oil repellent features in great demand post outbreak of COVID-19 12
Slide 14: Global Customer Reach
Global Customer Reach • Sales in 60+ countries including Brazil, Bangladesh, Germany, Indonesia, Malaysia, Singapore, Thailand, USA and Vietnam • 30+ technical marketing experts • 100+ dealers in Indian and International markets FY20 Revenue Mix 52% 48% Facilities at Mahape and Ambernath (upcoming),
Slide 15: Strategic Direction
Strategic Direction Leverage Fineotex’s industry insights and long standing customer relationships with Biotex’s high end product expertise and regional positioning to serve global customers Fineotex+ Biotex Synergies Upcoming brownfield facility at Ambernath, Maharashtra to be future ready for next
Slide 16: State-of-the-Art R&D Infrastructure
State-of-the-Art R&D Infrastructure • One of the finest R&D capabilities in the industry • State-of-the-art technology that is constantly updated through our in-house R&D facilities Overview • Capabilities to develop and customize products to adhere to client requirements • Modern Equipment such as
Slide 17: Sustainability Approach
Sustainability Approach 16
Slide 18: Board of Directors
Board of Directors Surendrakumar Tibrewala Sanjay Tibrewala Aarti Jhunjhunwala Navin Mittal Chairman and Managing Director Executive Director Executive Director Independent Director Alok Dhanuka CS Bindu Shah Dr. Anand Patwardhan Dr. Sunil Waghmare Independent Director Independent Director Independe
Slide 19: Newly Appointed Independent Directors as on 31st October 2020
Newly Appointed Independent Directors as on 31st October 2020 Name Brief Profile • Dr. Anand Patwardhan aged 57, is a Ph.D. (technology) in chemical engineering, from ICT Mumbai University. He has 33 years of experience in industry as well as in academics • Presently he is working as a professor in
Slide 20: Management Team
Management Team Surendra Kumar Tibrewala Sanjay Tibrewala Aarti Jhunjhunwala Education: B.Com and LLB Education: B.Com and P.G. in Textile Education: B.Com and M.Com Chemicals and Processing Managing Director Chief Financial Officer Head - International Marketing Noa N. Ouakass Kedar Sankar Sonai Ra
Slide 21: Manufacturing Platforms (GMP Certified)
Manufacturing Platforms (GMP* Certified) Location Operating Facts Strategic Advantages • FY20 Production Volume: 20,440 MT • Strategically located plant near key port • Current Utilisation: 56% close to Mumbai with logistical advantage to textile hubs across North, West, South and • Peak Utilisation
Slide 22: Accreditations: Biotex Malaysia
Accreditations: Biotex Malaysia Certificate Value Proposition • Bluesign is recognized as a leading certification for sustainability in the global textile industry. As a partner, Biotex is committed to applying the bluesign system to meet the highest level of safety for both people and environment,
Slide 23: Accreditations: Fineotex India
Accreditations: Fineotex India Certificate Value Proposition • ISO 9001:2015 defines the guiding principles to create efficiencies by aligning and streamlining processes throughout the organization, create new opportunities, meet regulatory requirements, and help organizations expand into new market
Slide 24: Financial Performance
| 4 We Y : a pe! | h \, r Lh ‘ . . Bo, (i Lao Financial yer Performance a4. ih 5 A ; . | al
Slide 25: Consolidated Annual Performance Trend
Consolidated Annual Performance Trend Figures in Rs. Mn. Revenue from Operations and Gross Margin EBITDA and EBITDA Margin 44.5% 25.2% 42.1% 40.3% 21.9% 21.0% 37.3% 36.8% 36.0% 19.0% 19.3% 35.5% 17.4% 17.4% 33.1% 16.2% 1,963 347 342 1,823 277 295 300 266 277 1,344 1,429 1,528 1,435 1,020 1,099 165 F
Slide 26: Consolidated Balance Sheet and Return Ratios Trend
Consolidated Balance Sheet and Return Ratios Trend Figures (in Rs Mn) Mar-20 Sep-20 Cash Flow from Operations /EBITDA (%)* ST Debt 28 30 83% 83% LT Debt - - 65% Total Debt 28 30 49% Cash & Cash Equivalent 179 314 35% 21% Net Cash 151 284 15% Equity 1,760 1,939 Total debt/Equity 0.02x 0.02x FY 15 FY
Slide 27: Q3 FY2021 Consolidated Financial Highlights
Q3 FY2021 Consolidated Financial Highlights Performance Discussion: Rs 583.5 mn Rs 136.2 mn Rs 134.0 mn • Q3 FY21 revenue growth was driven by gradual Total Revenue EBITDA Net Profit increase in order book from our leading customers 40.1% 23.3% 23.0% • Focus on speciality finishing chemicals and inc
Slide 28: Consolidated Quarterly Performance Trend
Consolidated Quarterly Performance Trend Figures in Rs. Mn. Revenue from Operations and Gross Margin EBITDA and EBITDA Margin 36.5% 39.1% 40.1% 23.3% 34.4% 31.0% 18.2% 17.4% 15.4% 13.5% 547 584 136 521 436 100 304 80 76 41 Q3 FY 20 Q4 FY 20 Q1 FY 21 Q2 FY 21 Q3 FY 21 Q3 FY 20 Q4 FY 20 Q1 FY 21 Q2 FY
Slide 29: Consolidated P&L Summary: Q3 and 9M FY2021
Consolidated P&L Summary: Q3 and 9M FY2021 (Rs. Million) Q3 FY21 Q3 FY20 YoY% Q2 FY21 QoQ% 9M FY21 9M FY20 YoY% Revenue from Operations 583.5 520.5 12.1% 547.5 6.6% 1,434.9 1,527.5 (6.1%) COGS 349.6 330.7 5.7% 359.0 (2.6%) 918.3 965.9 (4.9%) Gross Profit 233.9 189.9 23.2% 188.5 24.1% 516.5 561.6 (8.
Slide 30: Disclaimer
Disclaimer This presentation contains statements that contain “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Fineotex Chemical Limited (“Fineotex Chemical” or the Company) future bus
Slide 31: Fineotex Chemical Limited
Fineotex Chemical Limited FINEOTEX CHEMICAL LIMITED (CIN Number: L24100MH2004PLC144295) 42-43, Manorama Chambers, S. V. Road Bandra (West), Mumbai - 400 050, India Phone: (+91 - 22) 26559174 / 75, (+91 - 22) 26559176 / 77 Email: info@fineotex.com www.fineotex.com 30
Fineotex Chemical — Investor Presentation (February 2021) on 6ix